Literature DB >> 26851769

Sex-specific effects of N-acetylcysteine in neonatal rats treated with hypothermia after severe hypoxia-ischemia.

Xingju Nie1, Danielle W Lowe2, Laura Grace Rollins3, Jessica Bentzley4, Jamie L Fraser5, Renee Martin6, Inderjit Singh7, Dorothea Jenkins8.   

Abstract

Approximately half of moderate to severely hypoxic-ischemic (HI) newborns do not respond to hypothermia, the only proven neuroprotective treatment. N-acetylcysteine (NAC), an antioxidant and glutathione precursor, shows promise for neuroprotection in combination with hypothermia, mitigating post-HI neuroinflammation due to oxidative stress. As mechanisms of HI injury and cell death differ in males and females, sex differences must be considered in translational research of neuroprotection. We assessed the potential toxicity and efficacy of NAC in combination with hypothermia, in male and female neonatal rats after severe HI injury. NAC 50mg/kg/d administered 1h after initiation of hypothermia significantly decreased iNOS expression and caspase 3 activation in the injured hemisphere versus hypothermia alone. However, only females treated with hypothermia +NAC 50mg/kg showed improvement in short-term infarct volumes compared with saline treated animals. Hypothermia alone had no effect in this severe model. When NAC was continued for 6 weeks, significant improvement in long-term neuromotor outcomes over hypothermia treatment alone was observed, controlling for sex. Antioxidants may provide insufficient neuroprotection after HI for neonatal males in the short term, while long-term therapy may benefit both sexes.
Copyright © 2016 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  N-acetylcysteine; Neonatal hypoxia ischemia; Neuroprotection; Redox regulation; Sex

Mesh:

Substances:

Year:  2016        PMID: 26851769      PMCID: PMC4903952          DOI: 10.1016/j.neures.2016.01.008

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  77 in total

1.  Dual action of NO synthases on blood flow and infarct volume consecutive to neonatal focal cerebral ischemia.

Authors:  Philippe Bonnin; Pierre-Louis Leger; Sonia Villapol; Nicolas Deroide; Pierre Gressens; Marc Pocard; Sylvain Renolleau; Olivier Baud; Christiane Charriaut-Marlangue
Journal:  Exp Neurol       Date:  2012-04-12       Impact factor: 5.330

2.  Gender-specific neuroprotection by 2-iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway.

Authors:  Cora H A Nijboer; Floris Groenendaal; Annemieke Kavelaars; Henrik H Hagberg; Frank van Bel; Cobi J Heijnen
Journal:  J Cereb Blood Flow Metab       Date:  2006-05-31       Impact factor: 6.200

3.  Beneficial effects of n-acetylcysteine on ischaemic brain injury.

Authors:  S Cuzzocrea; E Mazzon; G Costantino; I Serraino; L Dugo; G Calabrò; G Cucinotta; A De Sarro; A P Caputi
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

4.  High concentration of antioxidants N-acetylcysteine and mitoquinone-Q induces intercellular adhesion molecule 1 and oxidative stress by increasing intracellular glutathione.

Authors:  Tapan K Mukherjee; Anurag K Mishra; Srirupa Mukhopadhyay; John R Hoidal
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

5.  Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: short- and long-term outcome.

Authors:  E Bona; H Hagberg; E M Løberg; R Bågenholm; M Thoresen
Journal:  Pediatr Res       Date:  1998-06       Impact factor: 3.756

6.  Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.

Authors:  Mushfiquddin Khan; Bipanjeet Sekhon; Manu Jatana; Shailendra Giri; Anne G Gilg; Charanpal Sekhon; Inderjit Singh; Avtar K Singh
Journal:  J Neurosci Res       Date:  2004-05-15       Impact factor: 4.164

Review 7.  Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression.

Authors:  H Offner; A A Vandenbark; P D Hurn
Journal:  Neuroscience       Date:  2008-07-01       Impact factor: 3.590

Review 8.  Regulation of glutathione synthesis.

Authors:  Shelly C Lu
Journal:  Mol Aspects Med       Date:  2008-06-14

9.  Hypoxia-ischemia and therapeutic hypothermia in the neonatal mouse brain--a longitudinal study.

Authors:  Jennifer C Burnsed; Raul Chavez-Valdez; Mir Shanaz Hossain; Kalpashri Kesavan; Lee J Martin; Jiangyang Zhang; Frances J Northington
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

10.  Transcriptomic landscape of lncRNAs in inflammatory bowel disease.

Authors:  Aashiq H Mirza; Claus Hb Berthelsen; Stefan E Seemann; Xiaoyong Pan; Klaus S Frederiksen; Mogens Vilien; Jan Gorodkin; Flemming Pociot
Journal:  Genome Med       Date:  2015-05-13       Impact factor: 11.117

View more
  15 in total

1.  Sex Bias in Pathogenesis of Autoimmune Neuroinflammation: Relevance for Dimethyl Fumarate Immunomodulatory/Anti-oxidant Action.

Authors:  Zorica Stojić-Vukanić; Jelena Kotur-Stevuljević; Mirjana Nacka-Aleksić; Duško Kosec; Ivana Vujnović; Ivan Pilipović; Mirjana Dimitrijević; Gordana Leposavić
Journal:  Mol Neurobiol       Date:  2017-05-22       Impact factor: 5.590

2.  N-Acetylcysteine rapidly replenishes central nervous system glutathione measured via magnetic resonance spectroscopy in human neonates with hypoxic-ischemic encephalopathy.

Authors:  Hunter G Moss; Truman R Brown; Donald B Wiest; Dorothea D Jenkins
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-21       Impact factor: 6.200

3.  Therapeutic hypothermia for the treatment of neonatal hypoxia-ischemia: sex-dependent modulation of reactive astrogliosis.

Authors:  Rafael Bandeira Fabres; Ricardo Ribeiro Nunes; Marcel de Medeiros de Mattos; Mirella Kielek Galvan Andrade; Ana Paula Rodrigues Martini; Isadora D'Ávila Tassinari; Eduardo Farias Sanches; Luciano Stürmer de Fraga; Carlos Alexandre Netto
Journal:  Metab Brain Dis       Date:  2022-07-02       Impact factor: 3.655

Review 4.  Perinatal hypoxic-ischemic damage: review of the current treatment possibilities.

Authors:  A Frajewicki; Z Laštůvka; V Borbélyová; S Khan; K Jandová; K Janišová; J Otáhal; J Mysliveček; V Riljak
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

Review 5.  Mitochondrial dysfunction in perinatal asphyxia: role in pathogenesis and potential therapeutic interventions.

Authors:  Puneet K Samaiya; Sairam Krishnamurthy; Ashok Kumar
Journal:  Mol Cell Biochem       Date:  2021-09-01       Impact factor: 3.396

Review 6.  Sexually Dimorphic Outcomes after Neonatal Stroke and Hypoxia-Ischemia.

Authors:  Christiane Charriaut-Marlangue; Valérie C Besson; Olivier Baud
Journal:  Int J Mol Sci       Date:  2017-12-26       Impact factor: 5.923

Review 7.  Role of Antioxidants in Neonatal Hypoxic-Ischemic Brain Injury: New Therapeutic Approaches.

Authors:  Olatz Arteaga; Antonia Álvarez; Miren Revuelta; Francisco Santaolalla; Andoni Urtasun; Enrique Hilario
Journal:  Int J Mol Sci       Date:  2017-01-28       Impact factor: 5.923

Review 8.  Oxidative stress and endoplasmic reticulum (ER) stress in the development of neonatal hypoxic-ischaemic brain injury.

Authors:  Claire Thornton; Ana A Baburamani; Anton Kichev; Henrik Hagberg
Journal:  Biochem Soc Trans       Date:  2017-09-22       Impact factor: 5.407

9.  Neuroprotection with hypothermia and allopurinol in an animal model of hypoxic-ischemic injury: Is it a gender question?

Authors:  Javier Rodríguez-Fanjul; Cristina Durán Fernández-Feijóo; Míriam Lopez-Abad; Maria Goretti Lopez Ramos; Rafael Balada Caballé; Soledad Alcántara-Horillo; Marta Camprubí Camprubí
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

10.  Umbilical cord blood therapy modulates neonatal hypoxic ischemic brain injury in both females and males.

Authors:  Tayla R Penny; Yen Pham; Amy E Sutherland; Joohyung Lee; Graham Jenkin; Michael C Fahey; Suzanne L Miller; Courtney A McDonald
Journal:  Sci Rep       Date:  2021-08-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.